News
Five acquisitions in 2025—including Cargo and Allakos—have put Concentra Biosciences in the spotlight. Learn what’s behind ...
Take a closer look at the radiopharma new wave as Nuclidium and Actithera raise big to develop their platforms.
Discover new treatments like ART-123 advancing toward approval to prevent long-term nerve damage caused by ...
Vienna’s biotech sector soared to €22.7B in 2023, fueling innovation, research, and jobs. Discover what is driving the boom.
The companies Insmed, Cidara Therapeutics, and Cogent Biosciences bagged the biggest biotech funding rounds overall in June ...
Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...
Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for the better.
Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global policies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results